Nanyan Rao

624 total citations
26 papers, 373 citations indexed

About

Nanyan Rao is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Nanyan Rao has authored 26 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 14 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Nanyan Rao's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (7 papers) and Breast Lesions and Carcinomas (7 papers). Nanyan Rao is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (7 papers) and Breast Lesions and Carcinomas (7 papers). Nanyan Rao collaborates with scholars based in China, Switzerland and United States. Nanyan Rao's co-authors include Weijuan Jia, Fengxi Su, Shunrong Li, Kai Chen, Heran Deng, Jieqiong Liu, Yunjie Zeng, Erwei Song, Liang Jin and Jiannan Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Nanyan Rao

25 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanyan Rao China	12	176	163	84	83	56	26	373
Erik Škof Slovenia	11	173 1.0×	44 0.3×	37 0.4×	75 0.9×	35 0.6×	34	347
Polly W.Y. Lam China	10	184 1.0×	80 0.5×	116 1.4×	127 1.5×	10 0.2×	12	385
Jiewen Peng China	8	242 1.4×	130 0.8×	60 0.7×	48 0.6×	12 0.2×	12	471
Errol L. Berman United States	11	178 1.0×	50 0.3×	106 1.3×	75 0.9×	35 0.6×	15	435
Malek M. Safa United States	9	125 0.7×	91 0.6×	102 1.2×	31 0.4×	131 2.3×	26	357
Ekaterini Politi Greece	11	81 0.5×	65 0.4×	32 0.4×	106 1.3×	83 1.5×	29	487
Sameer Gupta India	14	225 1.3×	193 1.2×	48 0.6×	194 2.3×	35 0.6×	68	572
Brindusa Truta United States	11	351 2.0×	114 0.7×	358 4.3×	151 1.8×	45 0.8×	30	633
Ardaman Shergill United States	12	218 1.2×	96 0.6×	60 0.7×	74 0.9×	13 0.2×	70	387
W. Schroeder Germany	11	156 0.9×	41 0.3×	74 0.9×	294 3.5×	25 0.4×	18	651

Countries citing papers authored by Nanyan Rao

Since Specialization

Citations

This map shows the geographic impact of Nanyan Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanyan Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanyan Rao more than expected).

Fields of papers citing papers by Nanyan Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanyan Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanyan Rao. The network helps show where Nanyan Rao may publish in the future.

Co-authorship network of co-authors of Nanyan Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Nanyan Rao. A scholar is included among the top collaborators of Nanyan Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanyan Rao. Nanyan Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shunrong, Xiaolan Zhang, Jingwen Yan, et al.. (2024). The learning curve of the MS-TRAM/DIEP breast reconstruction by dual-trained breast surgeons. BMC Surgery. 24(1). 53–53. 2 indexed citations

Chen, Haizhu, Ziwei Zhou, Fengxi Su, et al.. (2024). Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapy. The Breast. 75. 103733–103733. 5 indexed citations

Jin, Liang, Yudong Li, Nanyan Rao, et al.. (2024). Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study. Chinese Journal of Cancer Research. 36(1). 55–65. 1 indexed citations

Wu, Wei, Jiewen Chen, Heran Deng, et al.. (2021). Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial. BMC Cancer. 21(1). 862–862. 11 indexed citations

Lin, Wanyi, Yaping Yang, Wenjing Zhong, et al.. (2020). <p>The Effect of Low and High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Non-Inferiority, Randomized Clinical Trial</p>. Cancer Management and Research. Volume 12. 12487–12496. 7 indexed citations

Tan, Luyuan, Liling Zhu, Lei Xin, et al.. (2019). <p>Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study</p>. Cancer Management and Research. Volume 11. 8379–8389. 13 indexed citations

Rao, Nanyan, et al.. (2018). Proof-of-Concept Study of 3-D–Printed Mold–Guided Breast-Conserving Surgery in Breast Cancer Patients. Clinical Breast Cancer. 18(5). e769–e772. 3 indexed citations

Li, Qiwei, et al.. (2017). Granulomatous Lobular Mastitis Associated with Mycobacterium abscessus in South China: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2017. 1–4. 7 indexed citations

Rao, Nanyan, Jiayin Qiu, Jiannan Wu, et al.. (2017). Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. Chemotherapy. 62(4). 246–255. 13 indexed citations

10.

Wu, Wei, Heran Deng, Nanyan Rao, et al.. (2017). Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial. Trials. 18(1). 497–497. 6 indexed citations

11.

Li, Qian, Tao Qin, Shunrong Li, et al.. (2017). Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study. Anticancer Research. 37(8). 4539–4547. 2 indexed citations

12.

Wang, Ying, Jieqiong Liu, Weijuan Jia, et al.. (2016). Comparison of the Therapeutic Efficacy of the Early and the Delayed Use of Vinorelbine-Based Regimens for Patients with Advanced Breast Cancer. Chemotherapy. 62(1). 71–79. 4 indexed citations

13.

Li, Shunrong, Fengtao Liu, Kai Chen, et al.. (2016). The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1–2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes. Medicine. 95(14). e3254–e3254. 8 indexed citations

14.

Jia, Haixia, Weijuan Jia, Yaping Yang, et al.. (2014). HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World Journal of Surgical Oncology. 12(1). 289–289. 20 indexed citations

15.

Zhao, Jianli, Jieqiong Liu, Kai Chen, et al.. (2014). What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Research and Treatment. 145(1). 113–128. 74 indexed citations

16.

Liu, Jieqiong, Heran Deng, Weijuan Jia, et al.. (2012). Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment. Journal of Cancer Research and Clinical Oncology. 138(5). 837–842. 20 indexed citations

17.

Chen, Kai, Liling Zhu, Weijuan Jia, et al.. (2011). Validation and comparison of models to predict non‐sentinel lymph node metastasis in breast cancer patients. Cancer Science. 103(2). 274–281. 22 indexed citations

18.

Deng, Heran, Lun Chen, Weijuan Jia, et al.. (2011). Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. Journal of Cancer Research and Clinical Oncology. 137(12). 1869–1874. 29 indexed citations

19.

Dickson, Mark A., Patricia LoRusso, E. A. Sausville, et al.. (2011). Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3078–3078. 2 indexed citations

20.

Beresford, Mark, Indra Tumur, J. Chakrabarti, et al.. (2010). A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer. Clinical Oncology. 23(3). 209–215. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact